Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew)

European Journal of Pharmacology

Volumn 508, Issue 1-3, 2005, Pages 231-238

  Cheng, Frankie H M ^a   Andrews, Paul L R ^b   Moreaux, Benoit ^c   Ngan, Man P ^a   Rudd, John A ^a   Sam, Tasia S W ^a   Wai, Man K ^a   Wan, Christina ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Dihydroergotamine; Emesis; Migraine; Nausea; Resiniferatoxin; Sumatriptan; Suncus murinus; Vanilloid

Indexed keywords

4 [1 [3,5 BIS(TRIFLUOROMETHYL)BENZOYL] 2 (PHENYLMETHYL) 4 PIPERIDINYL] N (2,6 DIMETHYLPHENYL) 1 ACETAMIDE HYDROXYBUTANEDIOATE; ACETAMIDE DERIVATIVE; ACETYLCHOLINE; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BEMESETRON; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DOMPERIDONE; INDOMETACIN; METHYSERGIDE; METOCLOPRAMIDE; ONDANSETRON; R 116301; RESINIFERATOXIN; RUTHENIUM RED; SCOPOLAMINE; SUMATRIPTAN; TACHYKININ; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INSECTIVORE; MIGRAINE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VOMITING;

ANIMALS; ANTIEMETICS; BUTANOLS; CAPSAICIN; CYCLOOXYGENASE INHIBITORS; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DITERPENES; DOMPERIDONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; INDOMETHACIN; METHYSERGIDE; METOCLOPRAMIDE; MIGRAINE DISORDERS; ONDANSETRON; RUTHENIUM RED; SCOPOLAMINE; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SHREWS; SUMATRIPTAN; TIME FACTORS; TROPANES; VOMITING;

EID: 12844252122     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.12.022     Document Type: Article

References (62)

1. R. Amann, and C.A. Maggi Ruthenium red as a capsaicin antagonist Life Sci. 49 1991 849 856
2. P.L.R. Andrews, Y. Torii, H. Saito, and N. Matsuki The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus Eur. J. Pharmacol. 307 1996 305 313
3. P.L.R. Andrews, F. Okada, A.J. Woods, H. Hagiwara, S. Kakaimoto, M. Toyoda, and N. Matsuki The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew Br. J. Pharmacol. 130 2000 1247 1254
4. L. Bartho, and E.S. Vizi Neurochemical evidence for the release of acetylcholine from the guinea-pig ileum myenteric plexus by capsaicin Eur. J. Pharmacol. 110 1985 125 127
5. D.T. Beattie, H.E. Connor, and R.M. Hagan Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headache Can. J. Pharmacol. 73 1995 871 877
6. S. Bevan, S. Hothi, G. Hughes, I.F. James, H.P. Rang, K. Shah, C.S. Walpole, and J.C. Yeats Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin Br. J. Pharmacol. 107 1992 544 552
7. K.R. Bley, R.M. Eglen, and E.H. Wong Characterization of 5-hydroxytryptamine-induced depolarizations in rat isolated vagus nerve Eur. J. Pharmacol. 260 1994 139 147
8. M.G. Buzzi, and M.A. Moskowitz The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater Br. J. Pharmacol. 99 1990 202 206
9. M.G. Buzzi, and M.A. Moskowitz Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine Cephalalgia 11 1991 165 168
10. M.G. Buzzi, M. Bonamini, and M.A. Moskowitz Neurogenic model of migraine Cephalalgia 15 1995 277 280
11. R. Capasso, A.A. Izzo, F. Borrelli, A. Russo, L. Sautebin, A. Pinto, F. Capasso, and N. Mascolo Effect of piperine, the active ingredient of black pepper, on intestinal secretion in mice Life Sci. 71 2002 2311 2317
12. 3 receptor antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache Headache 31 1991 296 297
13. F.M. Cutrer, D. Schoenfeld, V. Limmroth, N. Panahian, and M.A. Moskowitz Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin Br. J. Pharmacol. 114 1995 987 992
14. C.G.H. Dahlof, and R.J. Hargreaves Pathophysiology and pharmacology of migraine. Is there a place for anti-emetics in future treatment strategies Cephalalgia 18 1998 593 604
15. R.A. Davidoff Migraine, Manifestations, Pathogenesis and Management first ed. 1995 F.A. Davis Philadelphia, USA
16. F. De Ponti Pharmacology of emesis and gastrointestinal motility: implications for migraine Funct. Neurology 15 Suppl. 3 2000 43 49
17. L. Edvinsson A pathophysiological view of primary headache Funct. Neurology 15 Suppl. 3 2000 51 60
18. H.K. Iversen Experimental headache in humans Cephalalgia 15 1995 281 287
19. N. Jaecques, A. Lambrecht, L. Schiettekatte, and J. Waelkens Treatment of nausea and vomiting during migraine attacks with intravenous domperidone Postgrad. Med. J. 55 Suppl. 1 1979 51
20. 2 receptor subtypes in the Suncus murinus intestine Eur. J. Pharmacol. 381 1999 161 169
21. F.A. Javid, and R.J. Naylor Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus Br. J. Pharmacol. 127 1999 1867 1875
22. J.C. Jerman, S.J. Brough, R. Prinjha, M.H. Harries, J.B. Davis, and D. Smart Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology Br. J. Pharmacol. 130 2000 916 922
23. S.E. Jordt, and D. Julius Molecular basis for species-specific sensitivity to "hot" chili peppers Cell 108 2002 421 430
24. K.K.W. Kan, R.L. Jones, M.P. Ngan, and J.A. Rudd Action of prostanoids on the emetic reflex of Suncus murinus (the house musk shrew) Eur. J. Pharmacol. 477 2003 247 251
25. K.L. Kumar Recent advances in the acute management of migraine and cluster headaches J. Gen. Intern. Med. 9 1994 339 348
26. V. Limmroth, and S. Przywara Analgesics H.C. Diener Drug treatment of migraine and other headaches vol. 17 2000 Karger Basel 30 43
27. O. Linhart, O. Obreja, and M. Kress The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons Neuroscience 118 2003 69 74
28. L. Liu, A. Szallasi, and S.A. Simon A non-pungent resiniferatoxin analogue, phorbol 12-phenylacetate 13 acetate 20-homovanillate, reveals vanilloid receptor subtypes on rat trigeminal ganglion neurons Neuroscience 84 1998 569 581
29. C. Loisy, S. Beorchia, V. Centonze, J.R. Fozard, P.J. Schechter, and G.P. Tell Effects on migraine headache of MDL 722,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study Cephalalgia 5 1985 79 82
30. A. Mascia, J. Afra, and J. Schoenen Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological and therapeutic data Cephalalgia 18 1998 174 182
31. N. Matsuki, S. Ueno, T. Kaji, A. Ishihara, C.H. Wang, and H. Saito Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: a new experimental model Jpn. J. Pharmacol. 48 1988 303 306
32. W. McNeely, and K.L. Goa Diclofenac-potassium in migraine: a review Drugs 57 1999 991 1003
33. A.A. Megens, D. Ashton, J.C. Vermeire, P.C. Vermote, K.A. Hens, L.C. Hillen, J.F. Fransen, M. Mahieu, L. Heylen, J.E. Leysen, M.R. Jurzak, and F. Janssens Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl) benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist J. Pharmacol. Exp. Ther. 302 2002 696 709
34. D.D. Mitsikostas, M. Sanchez del Rio, and C. Waeber 5- Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis Cephalalgia 22 2002 384 394
35. M.A. Moskowitz The neurobiology of vascular head pain Ann. Neurol. 16 1984 157 168
36. M.A. Moskowitz, and M.G. Buzzi Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions J. Neurol. 238 Suppl. 1 1991 S18 S22
37. M. Nicolodi, and F. Sicuteri Triptans. A support to the central link between serotonin and acetylcholine in migraine Adv. Exp. Med. Biol. 467 1999 183 189
38. K. Nozaki, M.A. Moskowitz, and P. Boccalini CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges Br. J. Pharmacol. 106 1992 409 415
39. 1A-receptor agonists in Suncus murinus Jpn. J. Pharmacol. 64 1994 109 114
40. 2 receptor agonist in Suncus murinus Br. J. Pharmacol. 114 1995 931 934
41. C.M. Perry, and A. Markham Sumatriptan. An updated review of its use in migraine Drugs 55 1998 889 922
42. B.K. Ramussen, and J. Olesen Classification and symptoms H.C. Diener Drug treatment of migraine and other headaches vol. 17 2000 Karger Basel 16 23
43. U. Reuter, M. Sanchez del Rio, and M.A. Moskowitz Experimental models of migraine Funct. Neurology 15 Suppl. 3 2000 9 18
44. J. Rinder, A. Szallasi, and J.M. Lundberg Capsaicin-, resiniferatoxin-, and lactic acid-evoked vascular effects in the pig nasal mucosa in vivo with reference to characterization of the vanilloid receptor Pharmacol. Toxicol. 78 1996 327 335
45. J.A. Rudd, and M.K. Wai Genital grooming and emesis induced by vanilloids in Suncus murinus, the house musk shrew Eur. J. Pharmacol. 422 2001 185 195
46. J.A. Rudd, C.H. Cheng, R.J. Naylor, M.P. Ngan, and M.K. Wai Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew) Eur. J. Pharmacol. 374 1999 77 84
47. 3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew) Eur. J. Pharmacol. 472 2003 135 145
48. Y. Shiroshita, T. Koga, and H. Fukuda Capsaicin in the 4th ventricle abolishes retching and transmission of emetic vagal afferents to solitary nucleus neurons Eur. J. Pharmacol. 339 1997 183 192
49. J.E. Smith, J.F. Paton, and P.L.R. Andrews An arterially perfused decerebrate preparation of Suncus murinus (house musk shrew) for the study of emesis and swallowing Exp. Physiol. 87 2002 563 574
50. A. Someya, S. Horie, and T. Murayama Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells Eur. J. Pharmacol. 450 2002 131 139
51. Y. Sugiura, and J. Kitoh The median and lateral substantia gelatinosa in the cervical cord of the musk shrew (Suncus murinus) and its synaptic composition Anat. Embryol. 170 1984 21 28
52. A. Szallasi The vanilloid (capsaicin) receptor: receptor types and species differences Gen. Pharmacol. 25 1994 223 243
53. A. Szallasi, and P.M. Blumberg Vanilloid (capsaicin) receptors and mechanisms Pharmacol. Rev. 51 1999 159 212
54. C. Tassorelli, and M.G. Buzzi Animal models for the study of migraine: update and future perspective Funct. Neurology 11 1996 327 331
55. G.J. Ter Horst, W.J. Meijler, J. Korf, and R.H. Kemper Trigeminal nociception-induced cerebral Fos expression in the conscious rat Cephalalgia 21 2001 963 975
56. P. Tfelt-Hansen Drug treatment of migraine: acute treatment and migraine prophylaxis Curr. Opin. Neurol. 9 1996 211 213
57. P. Tfelt-Hansen, and P.R. Saxena 5-HT receptor antagonists in migraine prophylaxis H.C. Diener Drug treatment of migraine and other headaches vol. 17 2000 Karger Basel 279 287
58. Y. Torii, H. Saito, and N. Matsuki 5-Hydroxytryptamine is emetogenic in the house musk shrew Suncus murinus Naunyn-Schmiedeberg's Arch. Pharmacol. 344 1991 564 567
59. 3 receptor antagonists in Suncus murinus Jpn. J. Pharmacol. 55 1991 107 113
60. S. Ueno, N. Matsuki, and H. Saito Suncus murinus as a new experimental model for motion sickness Life Sci. 43 1988 413 420
61. D.J. Williamson, and R.J. Hargreaves Neurogenic inflammation in the context of migraine Microsc. Res. Tech. 53 2001 167 178
62. B.J. Yates, A.D. Miller, and J.B. Lucot Physiological basis and pharmacology of motion sickness: an update Brain Res. Bull. 47 1998 395 406